SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001567619-16-002255
Filing Date
2016-04-29
Accepted
2016-04-29 17:19:07
Documents
5
Period of Report
2016-06-09
Effectiveness Date
2016-04-29

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 14A h10035877x1_def14a.htm DEF 14A 536103
2 GRAPHIC h10035877x1_proxy1.jpg GRAPHIC 2910176
3 GRAPHIC h10035877x1_proxy2.jpg GRAPHIC 2288877
4 GRAPHIC logo_oncocyte.jpg GRAPHIC 68415
5 GRAPHIC sig_judithsegall.jpg GRAPHIC 105217
  Complete submission text file 0001567619-16-002255.txt   7933889
Mailing Address 1301 HARBOR BAY PARKWAY SUITE 100 ALAMEDA CA 94502
Business Address 1301 HARBOR BAY PARKWAY SUITE 100 ALAMEDA CA 94502 510-521-3390
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37648 | Film No.: 161608375
SIC: 2835 In Vitro & In Vivo Diagnostic Substances